Leap Therapeutics, Inc. (LPTX)

NASDAQ: LPTX · IEX Real-Time Price · USD

2.960

-0.040 (-1.33%)

At close: Apr 18, 2024, 4:00 PM

3.030

+0.070 (2.36%)

After-hours: Apr 18, 2024, 6:55 PM EDT

Leap Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-81.41	-54.6	-40.59	-37.59	-33.26	-23.14	-29.97	-25.63	-12.05	-25.45	Upgrade
Depreciation & Amortization	0.02	0.02	0.03	0.03	0.05	0.05	0.05	0.03	0	0.66	Upgrade
Share-Based Compensation	5.13	5.18	3.69	2.57	3.73	3.47	5.6	0.05	0.05	1.66	Upgrade
Other Operating Activities	32.52	0.36	1.72	-1.05	2.22	-6.41	1.94	0.23	3.9	5.11	Upgrade
Operating Cash Flow	-43.75	-49.04	-35.16	-25.96	-26.9	-26.03	-22.14	-25.34	-8.1	-18.02	Upgrade
Capital Expenditures	0	0	0	0.03	-0.09	0	-0.06	-0.14	0	-0.23	Upgrade
Acquisitions	48.97	0	0	0	0	0	0	0	0	0	Upgrade
Change in Investments	0	0	0	0	0	0	0	0	0	-36.58	Upgrade
Investing Cash Flow	48.97	0	0	0.03	-0.09	0	-0.06	-0.14	0	-36.8	Upgrade
Share Issuance / Repurchase	-0	0	98.22	48.92	15.25	16.27	49.19	0	0	46.89	Upgrade
Debt Issued / Paid	0	0	0	0	0	0	0.75	25.9	4.4	0	Upgrade
Other Financing Activities	-0.03	-0.21	-0.18	25.08	-0.44	-0.36	-2.17	-0.28	3.87	-	Upgrade
Financing Cash Flow	-0.03	-0.21	98.04	74	14.82	15.91	47.76	25.62	8.27	46.89	Upgrade
Exchange Rate Effect	-0.04	-0.16	-0.03	0.12	-0.22	0.67	-0.62	0.25	-0	-0.19	Upgrade
Net Cash Flow	5.14	-49.42	62.85	48.18	-12.39	-9.45	24.94	0.39	0.17	-7.93	Upgrade
Free Cash Flow	-43.75	-49.04	-35.16	-25.93	-26.99	-26.03	-22.2	-25.48	-8.1	-18.24	Upgrade
Free Cash Flow Margin	-	-	-2343.80%	-1728.80%	-	-	-	-	-	-	Upgrade
Free Cash Flow Per Share	-2.14	-4.33	-4.10	-4.37	-11.95	-18.41	-24.23	-27.13	-8.63	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).